Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Nrc Health (NRC) EBITDA Margin (2016 - 2026)

Nrc Health's EBITDA Margin history spans 16 years, with the latest figure at 13.27% for Q4 2025.

  • On a quarterly basis, EBITDA Margin rose 6405.0% to 13.27% in Q4 2025 year-over-year; TTM through Dec 2025 was 16.44%, a 1164.0% increase, with the full-year FY2025 number at 16.44%, up 1164.0% from a year prior.
  • EBITDA Margin hit 13.27% in Q4 2025 for Nrc Health, down from 22.36% in the prior quarter.
  • Over the last five years, EBITDA Margin for NRC hit a ceiling of 34.79% in Q3 2021 and a floor of 50.78% in Q4 2024.
  • Historically, EBITDA Margin has averaged 22.7% across 5 years, with a median of 26.07% in 2023.
  • Biggest five-year swings in EBITDA Margin: plummeted -8159bps in 2024 and later skyrocketed 6405bps in 2025.
  • Tracing NRC's EBITDA Margin over 5 years: stood at 33.62% in 2021, then decreased by -5bps to 32.09% in 2022, then decreased by -4bps to 30.81% in 2023, then tumbled by -265bps to 50.78% in 2024, then surged by 126bps to 13.27% in 2025.
  • Business Quant data shows EBITDA Margin for NRC at 13.27% in Q4 2025, 22.36% in Q3 2025, and 4.67% in Q2 2025.